EEMCX
Price
$11.91
Change
+$0.06 (+0.51%)
Updated
Dec 20 closing price
RNWFX
Price
$77.72
Change
+$0.12 (+0.15%)
Updated
Dec 20 closing price
Ad is loading...

EEMCX vs RNWFX

Header iconEEMCX vs RNWFX Comparison
Open Charts EEMCX vs RNWFXBanner chart's image
Columbia Emerging Markets C
Price$11.91
Change+$0.06 (+0.51%)
VolumeN/A
CapitalizationN/A
American Funds New World R5
Price$77.72
Change+$0.12 (+0.15%)
VolumeN/A
CapitalizationN/A
EEMCX vs RNWFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
EEMCX vs. RNWFX commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EEMCX is a Hold and RNWFX is a Buy.

FUNDAMENTALS
Fundamentals
RNWFX has more cash in the bank: 62.2B vs. EEMCX (784M). RNWFX pays higher dividends than EEMCX: RNWFX (1.51) vs EEMCX (0.00). EEMCX was incepted earlier than RNWFX: EEMCX (17 years) vs RNWFX (23 years). EEMCX is a more actively managed with annual turnover of: 44.00 vs. RNWFX (32.00). RNWFX has a lower initial minimum investment than EEMCX: RNWFX (250) vs EEMCX (2000). EEMCX annual gain was more profitable for investors over the last year : 7.97 vs. RNWFX (5.86). RNWFX return over 5 years is better than : 14.39 vs. EEMCX (-7.30).
EEMCXRNWFXEEMCX / RNWFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence17 years23 years-
Gain YTD6.8124.549150%
Front LoadN/AN/A-
Min. Initial Investment2000250800%
Min. Initial Investment IRA1000N/A-
Net Assets784M62.2B1%
Annual Yield % from dividends0.001.51-
Returns for 1 year7.975.86136%
Returns for 3 years-22.34-5.10438%
Returns for 5 years-7.3014.39-51%
Returns for 10 years26.9542.6763%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VTRS12.520.39
+3.22%
Viatris
TEO11.890.14
+1.19%
Telecom Argentina SA
DX12.570.14
+1.13%
Dynex Capital
INTT7.680.04
+0.52%
inTEST Corp
VIRX0.21N/A
-1.87%
Viracta Therapeutics